DexCom, Inc.

DXCMNASDAQHealthcare● Active

$72.86

+$0.27(+0.37%)

Market Cap$28.1B

P/E Ratio—

52W High$89.98

52W Low$54.11

Avg Volume5.3M

Open$73.35

Beta1.44

Free Cash Flow Financials Revenue

DexCom, Inc. (DXCM) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

DXCM · free cash flow · updated Jun 8, 2026

Core FCF metrics

DXCM · FCF · TTM · margin & CAGR

Free cash flow was $1.08B for FY2025 (fiscal year ending 2025-12-31), up 70.8% year-over-year The FCF margin was 23.1%. Five-year CAGR stands at +31.3%.

FY2025 Free Cash Flow$1.08B▲ +70.8% YoY

Trailing 12M (TTM)$1.43Btrailing 4 quarters sum

FCF Margin23.1%$1.08B ÷ revenue

3-Year CAGR+52.3%FY2022 → FY2025

5-Year CAGR+31.3%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

DXCM · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.44B(364M)$1.08B▲ +70.8%23.1%

FY2024$989.5M(359M)$630.7M▲ +23.2%15.6%

FY2023$748.5M(237M)$511.9M▲ +68.0%14.1%

FY2022$669.5M(365M)$304.7M▲ +471.7%10.5%

FY2021$442.5M(389M)$53.3M▼ 80.7%2.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

DXCM · P/FCF · FCF yield · FCF per share

DexCom, Inc. (DXCM) trades at a FCF yield of 5.08% and a price-to-free-cash-flow ratio of 19.9x. FCF per share stands at $3.66, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

5.08%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$3.66

TTM FCF ÷ Shares Outstanding

Price / FCF

x19.9

Share Price ÷ FCF per Share

EV / FCF (TTM)

x19.9

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

DXCM · cash flow statement · operating / investing / financing

For FY2025, DexCom, Inc. generated $1.44B in operating cash flow and spent 364M in capital expenditures, yielding $1.08B in free cash flow.

Operating Activities

+$1.44B

Cash from core business operations

2025-12-31

Investing Activities

+$536.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$1.69B

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.44B) − |CapEx| (364M) = FCF ($1.08B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

DXCM vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

DexCom, Inc.YOU

DXCM

$1.08B+70.8%23.1%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

DexCom, Inc. (DXCM) reported free cash flow of $1.08B for FY2025 (fiscal year ending 2025-12-31), up 70.8% year-over-year. The FCF margin was 23.1%.

Based on available data, DexCom, Inc. has maintained positive free cash flow for at least 12 fiscal year(s). FCF peaked at $1.08B in FY2025. The 5-year CAGR stands at +31.3%.

DexCom, Inc.'s FCF yield is 5.08% and price-to-FCF ratio is 19.9x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

DXCM free cash flow · 8 questions

DexCom, Inc. free cash flow was $1.08B for FY2025, up 70.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.43B.

DXCM free cash flowDXCM FCFDXCM FCF 2025DXCM free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · DexCom, Inc. · DexCom, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026